Victory Capital Management
SLXP

Victory Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Victory Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-83
Closed -$5K – 1268
2013
Q3 		$5K Buy
+83
New +$5.72K ﹤0.01% 1172

Other funds holding SLXP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Victory Capital Management's SLXP Position: Q4 2013 in Review

Victory Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q4 2013, closing a stake of 83 shares — an estimated $5K sold.

Victory Capital Management first reported a position in SLXP in Q3 2013 and held it in 1 quarter. The position peaked at $5K in Q3 2013. 245 funds tracked by Wall St. Rank hold SLXP as of Q4 2013.

  • Victory Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q4 2013 after selling out during the quarter.
  • Victory Capital Management sold 83 SALIX PHARMACEUTICALS LTD DEL shares in Q4 2013, an estimated $5K.
  • Victory Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 1 quarter.
  • Victory Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $5K in Q3 2013.
  • 245 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q4 2013.

Based on Victory Capital Management's 13F filing for Q4 2013, filed 12 Feb 2014.